Research and development focused on food, health, quality and packaging
First written in FY2016. 24 of 35 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Other".
- FY2026Lower R&D spending, development continuesAnnual report
「Total expenses related to R&D for the fiscal year were ¥5,236 million.」
R&D expenses declined from ¥5,362 million in the previous fiscal year to ¥5,236 million, while new product and technology development continued in soy sauce, related seasonings, soy milk and beverages, alcoholic beverages, biochemicals and related areas. - FY2026-H1RestatedAnnual report
「The Group's R&D activities amounted to ¥2,547 million during the interim cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the interim cumulative consolidated period.」
R&D expenses of ¥2,547 million were recorded, and it was reported that there were no material changes in the status of R&D activities. - FY2025AdvancedAnnual report
「Total expenses related to R&D for the fiscal year were ¥5,362 million.」
R&D expenses increased from ¥5,067 million in the previous fiscal year to ¥5,362 million. New product and technology development continued in the Itsudemo Shinsen series, related seasonings, soy milk and beverages, biochemicals and related areas. - FY2025-H1RestatedAnnual report
「The Group's R&D activities amounted to ¥2,564 million during the interim cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the interim cumulative consolidated period.」
R&D expenses for the interim period were ¥2,564 million, and it was reconfirmed that there were no material changes in the status of R&D activities. - FY2024Slight decline in R&D expenses; new product development continuesAnnual report
「Total expenses related to R&D for the fiscal year were ¥5,067 million. In the soy sauce business, new products were developed in the 620 mL and 450 mL sizes of Itsudemo Shinsen Koku-Uma Rich Premium Whole Soybean Soy Sauce, as well as for commercial processing use.」
R&D expenses declined from ¥5,174 million in the previous fiscal year to ¥5,067 million, while new product and technology development continued in soy sauce, related seasonings, soy milk, Del Monte beverages, alcoholic beverages and biochemicals. - FY2024-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥3,680 million during the third quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
R&D expenses were ¥3,680 million, and it was reconfirmed that there were no material changes in R&D activities in food and health, products and containers, quality improvement, biochemicals and related areas. - FY2024-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥2,344 million during the second quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
R&D expenses for the six months ended the second quarter were ¥2,344 million, and it was reconfirmed that there were no material changes in the status of R&D activities. - FY2024-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥1,170 million during the first quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
First-quarter R&D expenses were ¥1,170 million, and it was reconfirmed that there were no material changes in the status of R&D activities. - FY2023AdvancedAnnual report
「Total expenses related to R&D for the fiscal year were ¥5,174 million.」
R&D expenses were ¥5,174 million, up from ¥4,892 million in the previous fiscal year. Product and technology development progressed for limited-edition soy sauces, Gu-men and Uchi-no-Gohan products, tomato seasonings, unsweetened adjusted soy milk, jelly drinks and environmentally friendly straws. - FY2023-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥3,641 million during the third quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
R&D expenses for the nine months ended the third quarter were ¥3,641 million, and it was reconfirmed that there were no material changes in the status of R&D activities. - FY2023-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥1,150 million during the first quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
First-quarter R&D expenses were ¥1,150 million, and it was reconfirmed that there were no material changes in the status of R&D activities. - FY2022AdvancedAnnual report
「Total expenses related to R&D for the fiscal year were ¥4,892 million. The popular Itsudemo Shinsen series was expanded, and large airtight bottles of Shiboritate Nama-Shoyu 620 ml and Ajiwai Rich Reduced-Sodium Soy Sauce 620 ml were launched.」
R&D expenses were ¥4,892 million, and new product and technology development continued in soy sauce, related seasonings, soy milk, beverages, alcoholic beverages and biochemicals. - FY2022-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥3,481 million during the third quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
R&D expenses of ¥3,481 million were recorded, and it was reconfirmed that there were no material changes in the status of R&D activities. - FY2022-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥2,332 million during the second quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
R&D expenses of ¥2,332 million were recorded, and it was reconfirmed that there were no material changes in R&D activities in food and health, products and containers, quality improvement, biochemicals and related areas. - FY2022-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥1,192 million during the first quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
R&D expenses of ¥1,192 million were recorded, and it was reconfirmed that there were no material changes in the status of R&D activities. - FY2021AdvancedAnnual report
「The Group's research and development expenses for the fiscal year were related to R&D in the biochemical fields of its domestic and overseas food manufacturing and sales businesses and its other domestic businesses, and amounted to ¥4,758 million. The lineup of the popular Itsudemo Shinsen series was expanded, and development was also carried out on Itsudemo Shinsen Reduced-Sodium Soy Sauce Mild Fermentation, which uses proprietary fermentation technology.」
R&D expenses were ¥4,758 million, up from ¥4,373 million in the previous fiscal year. R&D continued in fermentation technology, soy sauce, food products, beverages, containers, quality improvement and biochemicals. - FY2021-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥3,386 million during the third quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
R&D expenses for the nine months ended the third quarter were ¥3,386 million, and it was reconfirmed that there were no material changes in the status of R&D activities. - FY2021-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥2,240 million during the second quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
R&D expenses were ¥2,240 million, and it was reported that there were no material changes in the status of R&D activities. - FY2021-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥1,093 million during the first quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
R&D expenses of ¥1,093 million were recorded, and it was reconfirmed that there were no material changes in the status of R&D activities. - FY2020AdvancedAnnual report
「The Group's research and development expenses for the fiscal year were related to R&D in the biochemical fields of its domestic and overseas food manufacturing and sales businesses and its other domestic businesses, and amounted to ¥4,373 million. In August 2019, the Kikkoman Central Research Institute in Noda, Chiba, was completed. An environment was established to strengthen and concentrate on basic and foundational research as the Group pursued new fields, and a pilot plant was newly installed to accumulate differentiating technologies with the aim of strengthening product development capabilities in existing businesses.」
R&D expenses were ¥4,373 million. The Kikkoman Central Research Institute was completed in August 2019, and a pilot plant was established for basic and foundational research and product development. - FY2020-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥3,087 million during the third quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
R&D expenses for the nine months ended the third quarter were ¥3,087 million, and it was reported that there were no material changes in the status of R&D activities. - FY2020-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥1,929 million during the second quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
R&D expenses for the six months ended the second quarter were ¥1,929 million, and it was reported that there were no material changes in the status of R&D activities. - FY2020-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥958 million during the first quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
First-quarter R&D expenses were ¥958 million, and it was reported that there were no material changes in the status of R&D activities. - FY2019AdvancedAnnual report
「The Group's research and development expenses for the fiscal year were related to R&D in the biochemical fields of its domestic and overseas food manufacturing and sales businesses and its other domestic businesses, and amounted to ¥3,816 million. During the fiscal year, in basic research and technology development, the Group received the Paper Award of the Japanese Society for Food Science and Technology for its work on evaluation technologies for nama-shoyu and pasteurized soy sauce and the systematization of the characteristics of Japanese soy sauce.」
R&D expenses were ¥3,816 million, and the Group received the Paper Award of the Japanese Society for Food Science and Technology for research on soy sauce evaluation technologies and related areas. R&D in new products, containers, quality improvement and biochemicals also continued. - FY2019-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥2,779 million during the third quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the third quarter cumulative consolidated period.」
R&D expenses for the nine months ended the third quarter were ¥2,779 million, and there were no material changes in the status of R&D activities. - FY2019-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥1,818 million during the second quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the second quarter cumulative consolidated period.」
R&D expenses for the six months ended the second quarter were ¥1,818 million, and there were no material changes in R&D activities. - FY2019-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥909 million during the first quarter cumulative consolidated period. There were no material changes in the status of the Group's R&D activities during the first quarter cumulative consolidated period.」
First-quarter R&D expenses were ¥909 million, and there were no material changes in R&D activities. - FY2018AdvancedAnnual report
「The Group's research and development expenses for the fiscal year were related to R&D in the biochemical fields of its domestic and overseas food manufacturing and sales businesses and its other domestic businesses, and amounted to ¥3,772 million. In basic research and technology development, the Group received the Japan Soy Sauce Technology Award for research on enzymes in koji mold that contribute to soy sauce brewing.」
R&D expenses of ¥3,772 million were recorded, and the Group received the Japan Soy Sauce Technology Award for research on koji mold enzymes related to soy sauce brewing. R&D in product development, containers, quality improvement and biochemicals also continued. - FY2018-Q2RestatedAnnual report
「The amount of group-wide research and development activities during the six months ended the second quarter was ¥1,784 million. There were no material changes in the status of our group's research and development activities during the six months ended the second quarter.」
Research and development expenses of ¥1,784 million were recorded, and it was stated that there were no material changes in the status of research and development activities. - FY2018-Q1RestatedAnnual report
「The amount of group-wide research and development activities during the three months ended the first quarter was ¥884 million. There were no material changes in the status of our group's research and development activities during the three months ended the first quarter.」
Research and development expenses for the first quarter were ¥884 million, and it was stated that there were no material changes in research and development activities. - FY2017AdvancedAnnual report
「Our group's research and development expenses for the consolidated fiscal year related to research and development in the biochemical field within the domestic and overseas food manufacturing and sales businesses and the domestic other businesses, and totaled ¥3,943 million.」
Research and development expenses increased to ¥3,943 million from ¥3,662 million the previous year. Research and development continued in brewing technology, food and health, new products, packaging, quality improvement and biochemicals. - FY2017-Q3RestatedAnnual report
「The amount of group-wide research and development activities during the nine months ended the third quarter was ¥2,822 million. There were no material changes in the status of our group's research and development activities during the nine months ended the third quarter.」
Research and development expenses for the nine months ended the third quarter were ¥2,822 million, and it was stated that there were no material changes in the status of research and development activities. - FY2017-Q2RestatedAnnual report
「The amount of group-wide research and development activities during the six months ended the second quarter was ¥1,881 million. There were no material changes in the status of our group's research and development activities during the six months ended the second quarter.」
Research and development expenses for the six months ended the second quarter were ¥1,881 million. The company stated that there were no material changes in the status of its research and development activities. - FY2017-Q1RestatedAnnual report
「The amount of group-wide research and development activities during the three months ended the first quarter was ¥927 million. There were no material changes in the status of our group's research and development activities during the three months ended the first quarter.」
Quarterly research and development expenses were ¥927 million, and the company stated that there were no material changes in the status of its research and development activities. - FY2016First statedAnnual report
「Our group's research and development expenses for the consolidated fiscal year related to research and development in the biochemical field within the domestic and overseas food manufacturing and sales businesses and the domestic other businesses, and totaled ¥3,662 million.」
Research and development areas included brewing technology, food and health, new products, packaging, quality improvement and biochemicals. Research and development expenses were ¥3,662 million.